Not recommended for individuals with a personal or family history of medullary thyroid carcinoma or MEN 2 syndrome
Duracin de accin: La diferencia ms significativa radica en la farmacocintica
Side Effects Across Different Dosage Levels Side effects typically intensify with each dose increase, though the pattern varies significantly between individuals: Starter Doses (Wegovy 0.25-0.5mg, Zepbound 2.5-5mg) Common: Mild nausea, reduced appetite, occasional constipation Less common: Mild heartburn, slight fatigue Rare at this stage: Severe vomiting, intense gastrointestinal distress Middle Doses (Wegovy 1-1.7mg, Zepbound 7.5-10mg) Common: Moderate nausea (often worse after meals), constipation, occasional vomiting, delayed gastric emptying (feeling full longer) Less common: Headaches, fatigue, sulfur burps, acid reflux Rare but reported: Hair thinning (typically temporary), gallbladder issues Maintenance Doses (Wegovy 2.4mg, Zepbound 12.5-15mg) Common: All of the above, potentially more pronounced Additional concerns: Muscle loss if protein intake isn't adequate Long-term considerations: Nutritional deficiencies due to reduced food intake, delayed gastric emptying Tolerance Development: Does the Effect Diminish Over Time
Las inyecciones pueden generar una prdida de peso significativa (hasta un 1522% del peso corporal), pero los resultados dependen de muchos factores, como la dieta y la actividad fsica
How real customers describe their experience
Bea S, Ko HY, Bae JH, et al
